fbpx

INOVIO Pharmaceuticals testing COVID-19 vaccine today

INOVIO Pharmaceuticals, Inc., the Plymouth Meeting-based pharmaceutical company, will test the first dose of its COVID-19 vaccine today on a healthy volunteer.

“This is a significant step forward in the global fight against COVID-19,” said Dr. J. Joseph Kim, INOVIO’s president and CEO. “Without a new safe and effective vaccine, the COVID-19 pandemic is likely to continue to threaten lives and livelihoods.”

Inovio has been working on the vaccine since January and is enrolling 40 healthy adult volunteers to test it. One million doses are expected to be available by year-end for additional trials and emergency use, pending appropriate regulatory guidance and funding.

Dawn Ouellette Nixon

Business Events

Diversity and Inclusion Summit

Monday, August 31, 2020
Diversity and Inclusion Summit

2020 Top 50 Fastest Growing Companies

Wednesday, September 09, 2020
2020 Top 50 Fastest Growing Companies

The Future of Higher Ed Summit

Tuesday, September 29, 2020
The Future of Higher Ed Summit

Forty Under 40

Wednesday, September 30, 2020
Forty Under 40